跳至主要内容
临床试验/EUCTR2007-004247-30-NL
EUCTR2007-004247-30-NL进行中(未招募)不适用

The Role of the Endocannabinoid System in Psychiatric Disorders and Symptoms: a Pharmacological fMRI study - THC-phMRI in patients

niversity Medical Center Utrecht0 个研究点开始时间: 2007年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Diagnosed with one psychiatric disorder (according to DSM-IV)
  • History of mild cannabis use for at least one year (<1/week and = 4/year)
  • Right-handedness, assessed with the Edinburgh Handedness Inventory
  • Written informed consent of the patient
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Any clinical significant abnormality of any clinical laboratory test, except for the predetermined psychiatric disorder, including urinary drug screening
  • Impaired physical health evaluated by medical history, physical (including neurological) examination and screening laboratory tests (see paragraph 8.3.1)
  • Current diagnosis alcohol and/or drug abuse (DSM-IV criteria)
  • Body Mass Index (B.M.I.) <18 kg/m2 or >28 kg/m2
  • Any subject who received any investigational medication within 90 days prior to the start of the study or who is scheduled to receive an investigational drug
  • The use of any medication within three weeks prior to the start of the study, except for paracetamol and medication for the psychiatric disorder
  • Claustrophobia
  • Metal objects in or around the body (braces, pacemaker, metal fragments)

研究者

相似试验